Cencora, Inc.

COR ·Healthcare, Medical Distribution, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $763.5M $1.64B $559.6M $-339.7M $687.4M $717.9M $488.6M $3.4M
Depreciation & Amortization $269.5M $249.3M $260.4M $258.8M $254.0M $259.8M $278.5M —
Depreciation $151.0M $132.1M $135.2M $137.7M $128.1M $121.8M $113.6M $123.9M
Amortization $118.5M $117.2M $126.1M $127.3M $125.9M $138.0M $165.8M $166.9M
Stock-Based Compensation $28.7M $28.0M $66.1M $25.9M $23.2M $28.5M $70.4M $34.6M
Net Cash from Operating Activities $2.65B $1.34B $-2.31B $3.13B $109.2M $3.35B $-2.72B $1.00B
Investing Activities
Capital Expenditures $226.0M $165.6M $119.4M $249.8M $183.2M $129.1M $105.9M $182.3M
Business Acquisitions $41.7M $4.71B $219.7M $91.4M $56.5M $3.94B $9.0M $45.3M
Net Cash from Investing Activities $-240.1M $-4.87B $-299.3M $-321.9M $-234.7M $-4.08B $-343.0M $-241.9M
Financing Activities
Dividends Paid $116.6M $117.5M $126.5M $107.5M $107.5M $111.2M $110.9M $100.9M
Stock Repurchases — — — $71.0K $0 $50.0M $385.4M $505.0M
Net Cash from Financing Activities $-1.77B $3.98B $43.2M $-683.8M $215.5M $-491.7M $3.21B $-957.3M
Net Change in Cash $628.7M $427.6M $-2.59B $2.12B $96.8M $-1.22B $97.1M $-178.5M
Free Cash Flow $2.43B $1.17B $-2.42B $2.88B $-74.0M $3.22B $-2.82B $818.1M
← Newer Page 1 of 9 Older →